Analysts Set InfuSystem Holdings, Inc. (NYSE:INFU) PT at $14.50

Shares of InfuSystem Holdings, Inc. (NYSE:INFU) have been assigned an average recommendation of “Buy” from the five analysts that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold rating, two have given a buy rating and two have assigned a strong buy rating to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $14.50.

Several equities analysts recently commented on INFU shares. Zacks Research lowered InfuSystem from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 6th. Roth Capital reaffirmed a “buy” rating and set a $14.00 price objective (up previously from $13.00) on shares of InfuSystem in a research note on Tuesday, November 4th. Finally, Lake Street Capital began coverage on shares of InfuSystem in a report on Monday, September 22nd. They set a “buy” rating and a $15.00 price objective on the stock.

Hedge Funds Weigh In On InfuSystem

Hedge funds have recently made changes to their positions in the stock. Bank of America Corp DE raised its position in shares of InfuSystem by 19.4% in the 2nd quarter. Bank of America Corp DE now owns 17,994 shares of the company’s stock worth $112,000 after buying an additional 2,924 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of InfuSystem by 0.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 569,238 shares of the company’s stock worth $5,898,000 after purchasing an additional 4,430 shares during the period. CWM LLC raised its holdings in shares of InfuSystem by 1,160.1% in the 2nd quarter. CWM LLC now owns 4,826 shares of the company’s stock worth $30,000 after purchasing an additional 4,443 shares during the period. Legato Capital Management LLC lifted its stake in shares of InfuSystem by 5.5% in the 3rd quarter. Legato Capital Management LLC now owns 86,745 shares of the company’s stock valued at $899,000 after purchasing an additional 4,534 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in shares of InfuSystem during the 2nd quarter worth about $33,000. Institutional investors and hedge funds own 71.13% of the company’s stock.

InfuSystem Stock Down 1.6%

INFU stock opened at $8.96 on Monday. The company has a 50 day moving average price of $9.55 and a two-hundred day moving average price of $8.68. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98. The stock has a market capitalization of $182.21 million, a P/E ratio of 149.36 and a beta of 1.71. InfuSystem has a one year low of $4.61 and a one year high of $11.04.

About InfuSystem

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.